XML 23 R13.htm IDEA: XBRL DOCUMENT
v3.25.2

Supplementary Financial Information | 9 Months Ended
--- | ---
Jul. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Supplementary Financial Information | Supplementary Financial Information Cash, Cash Equivalents and Restricted Cash
| As of
| July 31, 2025 |  | October 31, 2024
| In millions
Cash and cash equivalents | $ | 2,871 |  |  | $ | 3,238 |
Restricted cash(1) | 3 |  |  | 15 |
| $ | 2,874 |  |  | $ | 3,253 |
(1) Restricted cash is related to amounts collected and held on behalf of a third party for trade receivables previously sold. Accounts Receivable The allowance for credit losses related to accounts receivable and changes were as follows:
| Nine months ended July 31, 2025
| In millions
Balance at beginning of period | $ | 83 |
Current-period allowance for credit losses | 6 |
Deductions, net of recoveries | (6) |
Balance at end of period | $ | 83 |
HP utilizes certain third-party arrangements in the normal course of business as part of HPs cash and liquidity management and also to provide liquidity to certain partners to facilitate their working capital requirements. These financing arrangements, which in certain circumstances may contain partial recourse, result in a transfer of HP’s receivables and risk to the third-party. As these transfers qualify as true sales under the applicable accounting guidance, the receivables are de-recognized from the Condensed Consolidated Balance Sheets upon transfer, and HP receives a payment for the receivables from the third-party within a mutually agreed upon time period. For arrangements involving an element of recourse, the recourse obligation is measured using market data from similar transactions and reported as a current liability in the Condensed Consolidated Balance Sheets. The recourse obligations as of July 31, 2025 and October 31, 2024 were not material. The following is a summary of the activity under these arrangements:
| Three months ended July 31 |  | Nine months ended July 31
| 2025 |  | 2024 |  | 2025 |  | 2024
| In millions
Balance at beginning of period(1) | $ | 217 |  |  | $ | 181 |  |  | $ | 284 |  |  | $ | 141 |
Trade receivables sold | 3,085 |  |  | 3,111 |  |  | 9,259 |  |  | 9,256 |
Cash receipts | (3,184) |  |  | (2,983) |  |  | (9,431) |  |  | (9,089) |
Foreign currency and other | 2 |  |  | 3 |  |  | 8 |  |  | 4 |
Balance at end of period(1) | $ | 120 |  |  | $ | 312 |  |  | $ | 120 |  |  | $ | 312 |
(1) Amounts outstanding from third parties reported in Accounts receivable in the Condensed Consolidated Balance Sheets. Inventory
| As of
| July 31, 2025 |  | October 31, 2024
| In millions
Finished goods | $ | 4,800 |  |  | $ | 4,338 |
Purchased parts and fabricated assemblies | 3,556 |  |  | 3,382 |
| $ | 8,356 |  |  | $ | 7,720 |
Other Current Assets
| As of
| July 31, 2025 |  | October 31, 2024
| In millions
Prepaid and other current assets | $ | 1,624 |  |  | $ | 1,462 |
Supplier and other receivables | 1,619 |  |  | 2,180 |
Value-added taxes receivable | 978 |  |  | 1,028 |
| $ | 4,221 |  |  | $ | 4,670 |
Property, Plant and Equipment, Net
| As of
| July 31, 2025 |  | October 31, 2024
| In millions
Land, buildings and leasehold improvements | $ | 2,612 |  |  | $ | 2,527 |
Machinery and equipment, including equipment held for lease | 5,816 |  |  | 5,465 |
| 8,428 |  |  | 7,992 |
Accumulated depreciation | (5,435) |  |  | (5,078) |
| $ | 2,993 |  |  | $ | 2,914 |
Other Non-Current Assets
| As of
| July 31, 2025 |  | October 31, 2024
| In millions
Deferred tax assets | $ | 3,424 |  |  | $ | 3,311 |
Right-of-use assets | 1,092 |  |  | 1,165 |
Intangible assets(1) | 1,071 |  |  | 1,319 |
Prepaid pension and post-retirement benefit assets | 402 |  |  | 362 |
Deposits and prepaid | 317 |  |  | 322 |
Other | 1,267 |  |  | 1,129 |
| $ | 7,573 |  |  | $ | 7,608 |
(1) During the three and nine months ended July 31, 2025, the Company incurred impairment charges of $65 million related to acquired customer contracts, customer lists and distribution agreements within the Print segment and $27 million of technology and patents within the Corporate Investments segments. Other Current Liabilities
| As of
| July 31, 2025 |  | October 31, 2024
| In millions
Sales and marketing programs | $ | 2,856 |  |  | $ | 3,060 |
Deferred revenue | 1,548 |  |  | 1,446 |
Other accrued taxes | 1,181 |  |  | 1,233 |
Employee compensation and benefits | 849 |  |  | 970 |
Warranty | 409 |  |  | 486 |
Operating lease liabilities | 409 |  |  | 443 |
Tax liability | 248 |  |  | 291 |
Other | 2,559 |  |  | 2,449 |
| $ | 10,059 |  |  | $ | 10,378 |
Other Non-Current Liabilities
| As of
| July 31, 2025 |  | October 31, 2024
| In millions
Deferred revenue | $ | 1,588 |  |  | $ | 1,487 |
Operating lease liabilities | 764 |  |  | 787 |
Tax liability | 620 |  |  | 839 |
Pension, post-retirement, and post-employment liabilities | 598 |  |  | 607 |
Deferred tax liability | 15 |  |  | 31 |
Other | 524 |  |  | 531 |
| $ | 4,109 |  |  | $ | 4,282 |
Interest and Other, Net
| Three months ended July 31 |  | Nine months ended July 31
| 2025 |  | 2024 |  | 2025 |  | 2024
| In millions
Interest expense on borrowings | $ | (111) |  |  | $ | (111) |  |  | $ | (329) |  |  | $ | (343) |
Factoring costs | (32) |  |  | (38) |  |  | (101) |  |  | (117) |
Certain litigation benefits | 52 |  |  | — |  |  | 52 |  |  | — |
Non-operating retirement-related credits | 3 |  |  | 4 |  |  | 13 |  |  | 10 |
Other, net | (4) |  |  | 32 |  |  | (16) |  |  | 40 |
| $ | (92) |  |  | $ | (113) |  |  | $ | (381) |  |  | $ | (410) |
Net Revenue by Region
| Three months ended July 31 |  | Nine months ended July 31
| 2025 |  | 2024 |  | 2025 |  | 2024
| In millions
Americas | $ | 6,107 |  |  | $ | 6,086 |  |  | $ | 17,419 |  |  | $ | 17,085 |
Europe, Middle East and Africa | 4,502 |  |  | 4,420 |  |  | 13,649 |  |  | 13,461 |
Asia-Pacific and Japan | 3,323 |  |  | 3,013 |  |  | 9,588 |  |  | 8,958 |
Total net revenue | $ | 13,932 |  |  | $ | 13,519 |  |  | $ | 40,656 |  |  | $ | 39,504 |
Value of Remaining Performance Obligations As of July 31, 2025, the estimated value of transaction price allocated to remaining performance obligations was $4.0 billion. HP expects to recognize approximately $1.8 billion of the unearned amount in next 12 months and $2.2 billion thereafter. HP has elected the practical expedients and accordingly does not disclose the aggregate amount of the transaction price allocated to remaining performance obligations if: •the contract has an original expected duration of one year or less; or •the revenue from the performance obligation is recognized over time on an as-invoiced basis when the amount corresponds directly with the value to the customer; or •the portion of the transaction price that is variable in nature is allocated entirely to a wholly unsatisfied performance obligation. The remaining performance obligations are subject to change and may be affected by various factors, such as termination of contracts, contract modifications and adjustment for currency. Contract Liabilities As of July 31, 2025 and October 31, 2024, HP’s contract liabilities balances were $3.1 billion and $2.9 billion, respectively, included in Other current liabilities and Other non-current liabilities in the Condensed Consolidated Balance Sheets. The increase in the contract liabilities balance for the nine months ended July 31, 2025, was primarily driven by sales of fixed-price support and maintenance services, partially offset by $1.2 billion of revenue recognized that was included in the contract liabilities balance as of October 31, 2024. Supplier Finance Program s HP facilitates voluntary supplier finance programs to provide certain suppliers the opportunity to sell their right to HP’s payment obligations to participating financial institutions. Under these programs, HP agrees to pay the participating financial institutions the stated amount of confirmed invoices from its designated suppliers on the original maturity dates of the invoices. Participation by suppliers in these programs have no impact on the payment terms and amounts due from HP. HP does not have an economic interest in a supplier's participation in the program and is not a party to the agreement between the supplier and the financial institutions. In connection with these programs, HP does not pledge assets or other forms of guarantees as security for the committed payment to the participating financial institutions. For certain programs, HP pays a monthly service fee to a third-party administrato r that provides the supplier finance platform and related support. HP and the participating financial institutions may terminate the agreement upon at least 30 days notice. As of July 31, 2025 and October 31, 2024, HP had $8.6 billion and $7.8 billion respectively, in obligations outstanding (i.e., unpaid invoices) that were confirmed as valid under the supplier finance programs, of which $0.5 billion and $0.9 billion were owed to participating financial institutions. These obligations are included within the Accounts payable line item of HP’s Condensed Consolidated Balance Sheets. As of both July 31, 2025 and October 31, 2024, the Company’s outstanding payment obligations that suppliers elected to sell to participating financial institutions were $0.1 billion.

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration